NEVVI Medicare utilization intelligence

← back

NATARAJAN, NAGENDRAMD.,MPH NPI 1124245618 Clinician

Medical Oncology · OMAHA, NE

Specialty Medical Oncology — from billed Medicare claims
In practice about 24 years since medical school (class of 2002, self-reported to CMS)
Location OMAHA, NE · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 64 codes billed · 68,482 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ONCOLOGY HEMATOLOGY WEST PC
2019–2026
THINK AKSARBEN LLC
2021

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-10

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J0897 Injection, denosumab, 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1100 Injection, dexamethasone sodium phosphate, 1 mg
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2469 Injection, palonosetron hcl, 25 mcg
J2405 Injection, ondansetron hydrochloride, per 1 mg
J0640 Injection, leucovorin calcium, per 50 mg
J9190 Injection, fluorouracil, 500 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
96375 Injection of additional new drug or substance into vein
83615 Lactate dehydrogenase (enzyme) level
J9045 Injection, carboplatin, 50 mg
J3480 Injection, potassium chloride, per 2 meq
96413 Administration of chemotherapy into vein, 1 hour or less
82728 Ferritin (blood protein) level
84443 Blood test, thyroid stimulating hormone (tsh)
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96372 Injection of drug or substance under skin or into muscle
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
82533 Cortisol (hormone) measurement, total
J1200 Injection, diphenhydramine hcl, up to 50 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
82607 Cyanocobalamin (vitamin b-12) level
J3489 Injection, zoledronic acid, 1 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
83735 Magnesium level
96417 Administration of additional new drug or substance into vein, 1 hour or less
80048 Blood test, basic group of blood chemicals (calcium, total)
96361 Infusion into a vein for hydration, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
J3490 Unclassified drugs
36415 Insertion of needle into vein for collection of blood sample
81002 Urinalysis, manual test
96523 Irrigation of implanted venous access drug delivery device
96411 Administration of additional new drug or substance into vein using push technique
84153 Psa (prostate specific antigen) measurement, total
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
82378 Carcinoembryonic antigen (cea) protein level
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
96360 Infusion into a vein for hydration, 31-60 minutes
85046 Red blood count automated, with additional calculations
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
88184 Flow cytometry technique for dna or cell analysis, first marker
84100 Phosphate level
96374 Injection of drug or substance into vein
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
84439 Thyroxine (thyroid chemical), free
82565 Blood creatinine level
G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.